| 8217-2 |
Opiates |
MCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Opiates [Mass/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
8217-2 |
|
|
|
|
Both |
|
|
|
0 |
Opiates SerPl-mCnc |
|
|
|
Y |
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; Level; Mass concentration; OP; Opi; Opiate; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
| 82170-2 |
Influenza virus B RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Influenza virus B RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82170-2 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
FLUBV RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; FLUB; FLUBV; FLUV; ID; Infectious Disease; InfectiousDisease; Influ; Influenza B; Influenza B virus; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82171-0 |
Parainfluenza virus 1 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Parainfluenza virus 1 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82171-0 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV1 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV1; Human respirovirus 1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 1; Parainfluenza type I; PCR; PI1; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82172-8 |
Parainfluenza virus 2 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Parainfluenza virus 2 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82172-8 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV2 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV2; Human rubulavirus 2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 2; Parainfluenza type II; PCR; PI2; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82173-6 |
Parainfluenza virus 3 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Parainfluenza virus 3 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82173-6 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV3 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV3; Human respirovirus 3; ID; III; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; Parainfluenza type 3; Parainfluenza type III; PCR; PI3; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82174-4 |
Parainfluenza virus 4 RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Parainfluenza virus 4 RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82174-4 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HPIV4 RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HPIV; HPIV4; Human rubulavirus 4; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; Para; Parainflu; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Ribonucleic acid; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82175-1 |
Rhinovirus+Enterovirus RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Rhinovirus+Enterovirus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82175-1 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
RV+EV RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; Entero virus; EV; EV-PCR; HRV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Rhino virus; RHV; Ribonucleic acid; RV+EV; RV+EV RNA; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82176-9 |
Respiratory syncytial virus RNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Respiratory syncytial virus RNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82176-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
RSV RNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; DNA NUCLEIC ACID PROBE; DNA probe; HRSV; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Lung; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; Pulmonary; Pulmonology; QBR; QL; Qual; Qualitative; Random; Respiratory; Ribonucleic acid; RSV; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82177-7 |
Mycoplasma pneumoniae DNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Mycoplasma pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82177-7 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
M pneumo DNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Enzootic pneumonia; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; M pneumo; M pneumonia; M pneumoniae; Microbiology; Myco; Myco pneu; Mycoplas; Mycoplasm; Mycoplasmoides pneumoniae; Mycoplasmosis; Mycoplsm; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82178-5 |
Chlamydophila pneumoniae DNA |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Chlamydophila pneumoniae DNA [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82178-5 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
C pneum DNA Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C pneum; C pneumo; C pneumoniae; Chlamydia; Chlamydia pneumoniae; CPN; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Twar agent |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82179-3 |
Bordetella pertussis.pertussis toxin promoter region |
PrThr |
Nph |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Bordetella pertussis.pertussis toxin promoter region [Presence] in Nasopharynx by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82179-3 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
B pert.PT Prmt Nph Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; B pert; B pert.PT; B pert.PT Prmt; B pertussis; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Nasopharynx; Nucleic acid sequence based analysis; Ordinal; PCR; Pertussis; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification; Whooping cough |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Changed Bordetella pertussis toxin to Bordetella pertussis.pertussis toxin for accuracy. |
0 |
| 8218-0 |
Opiates |
PrThr |
Ser/Plas |
Pt |
Ord |
Confirm |
|
ACTIVE |
Opiates [Presence] in Serum or Plasma by Confirmatory method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
8218-0 |
|
Confirm |
|
|
Both |
|
|
|
0 |
Opiates SerPl Ql Cfm |
|
|
|
|
|
Addiction; Cfm; CNFR; CNFRM; Conf; Confirmation; Confirmatory; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; GCMS; Heroin; Illicit; LC/MS/MS; OP; Opi; Opiate; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Screen; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 82180-1 |
Meningitis+Encephalitis pathogens panel |
- |
CSF |
Pt |
- |
Non-probe.amp.tar |
|
ACTIVE |
Meningitis+Encephalitis pathogens panel - Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
PANEL.MICRO |
|
82180-1 |
|
Non-probe.amp.tar |
|
|
Order |
|
|
|
0 |
Mening+Enc Pnl CSF NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; DNA NUCLEIC ACID PROBE; DNA probe; Enc; Enceph; Encephalomyelitis; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Mening+Enc Pnl; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Pan; PANEL.MICROBIOLOGY; Panl; PCR; Pnl; Point in time; Polymerase chain reaction; Probe amp; Probe with ampification; Probe with target amplification; QBR; Random; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
Panel |
|
|
|
|
|
|
|
|
Release 2.72: COMPONENT: Removed "DNA & RNA" from panel name because it is implied based on the Method.; |
0 |
| 82181-9 |
Cryptococcus gattii+neoformans DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Cryptococcus gattii+neoformans DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82181-9 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
C gattii+neofor DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; C gattii+neofor; C. gattii; Cerebral spinal fluid; Cerebrospinal Fl; Crypt; Crypto; Cryptococcal; Cryptococcosis; Cryptococcosus; Cryptococcus neoformans var gattii; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
Updated Shortname override. |
0 |
| 82182-7 |
Escherichia coli K1 DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Escherichia coli K1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82182-7 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
E coli K1 DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; E coli; E coli K1; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; o002; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82183-5 |
Haemophilus influenzae DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Haemophilus influenzae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82183-5 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
Haem influ DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; H flu; H influenza; H influenzae; Haem influ; Haemoph; ID; Infectious Disease; InfectiousDisease; Influ; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82184-3 |
Listeria monocytogenes DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Listeria monocytogenes DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82184-3 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
L monocytog DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; L monocytog; L monocytogenes; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Listeriosis; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82185-0 |
Neisseria meningitidis DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Neisseria meningitidis DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82185-0 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
N men DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Mening; Meningid; Meningitis; Meningo; Meningococcal meningitis; Meningococcus; Microbiology; N men; N menigitidis; N meningitidis; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82186-8 |
Streptococcus agalactiae DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Streptococcus agalactiae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82186-8 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
Gp B Strep DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; GBS; Gp B Strep; Group B; Group B Strep; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S agalactiae; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Steptococcus Group B; Strand Displacement Amplification; Strep; Strep B; Strep group B; Strept; Streptococci group B; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82187-6 |
Streptococcus pneumoniae DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Streptococcus pneumoniae DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82187-6 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
S pneum DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Pneu; pneum; Pneumo; Pneumococ; Pneumococcal; Pneumococcal pneumonia; Pneumococcus; Pneumon; Pneumonia; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; S pneumo; S pneumoniae; S pneumoniase DNA; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Spn; Strand Displacement Amplification; Strep; Strept; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82188-4 |
Varicella zoster virus DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82188-4 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
VZV DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Chicken pox; Chicken pox virus; Chickenpox; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herpes zoster; HHV-3; Human herpesvirus 3; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Shingles; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification; VZ; VZV; Zoster |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82189-2 |
Cytomegalovirus DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Cytomegalovirus DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82189-2 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
CMV DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; CMV; Cytomegalo virus; Cytomgal; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; HHV-5; Human Herpesvirus-5; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 8219-8 |
Opiates |
PrThr |
Ser/Plas |
Pt |
Ord |
Screen |
|
ACTIVE |
Opiates [Presence] in Serum or Plasma by Screen method |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
DRUG/TOX |
|
8219-8 |
|
Screen |
|
|
Both |
|
|
|
0 |
Opiates SerPl Ql Scn |
|
|
|
|
|
Addiction; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Heroin; Illicit; OP; Opi; Opiate; Ordinal; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; PR; QL; Qual; Qualitative; Random; Scn; Scr; Screen; Scrn; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR |
2.73 |
1.0h(2) |
|
|
|
|
|
|
|
|
|
|
The Property has been changed from ACnc to reflect new model for ordinal terms; The PrThr property is used for LOINC terms whose results are reported using an ordered categorical scale, regardless of whether or not an internal threshold was used to make that determination. This change was approved by the Laboratory LOINC Committee in June 2016. |
0 |
| 82190-0 |
Herpes simplex virus 1 DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Herpes simplex virus 1 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82190-0 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HSV1 DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 1; HSV; HSV1; i; ID; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
| 82191-8 |
Herpes simplex virus 2 DNA |
PrThr |
CSF |
Pt |
Ord |
Non-probe.amp.tar |
|
ACTIVE |
Herpes simplex virus 2 DNA [Presence] in Cerebral spinal fluid by NAA with non-probe detection |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
82191-8 |
|
Non-probe.amp.tar |
|
|
Both |
|
|
|
0 |
HSV2 DNA CSF Ql NAA+non-probe |
|
|
|
|
|
3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Cerebral spinal fluid; Cerebrospinal Fl; Deoxyribonucleic acid; DNA NUCLEIC ACID PROBE; DNA probe; Herp splx; Herpes simplex virus type 2; Herpes simplex virus type II; HSV; HSV2; ID; II; Infectious Disease; InfectiousDisease; LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Microbiology; NAA+non-probe; NAA+probe; NAAT; NASBA; Neuro; Neurology; Nucleic acid sequence based analysis; Ordinal; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Spinal Fl; Spinal Fld; Spinal Flu; Spinal Fluid; Strand Displacement Amplification; TMA; Transcription mediated amplification |
2.73 |
2.56 |
|
|
|
|
|
|
|
|
|
|
|
0 |
